VEGF and Delta-Notch: interacting signalling pathways in tumour angiogenesis View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2008-09-30

AUTHORS

G Thurston, J Kitajewski

ABSTRACT

Tumour angiogenesis has become an important target for antitumour therapy, with most current therapies aimed at blocking the VEGF pathway. However, not all tumours are responsive to VEGF blockers, and some tumours that are responsive initially may become resistant during the course of treatment, thus there is a need to explore other angiogenesis signalling pathways. Recently, the Delta-Notch pathway, and particularly the ligand Delta-like 4 (Dll4), was identified as a new target in tumour angiogenesis. An important feature in angiogenesis is the manifold ways in which the VEGF and Delta-Notch pathways interact. The emerging picture is that the VEGF pathway acts as a potent upstream activating stimulus for angiogenesis, whereas Delta-Notch helps to guide cell fate decisions that appropriately shape the activation. Here we review the two signalling pathways and what is currently known about the ways in which they interact during tumour angiogenesis. More... »

PAGES

1204-1209

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.bjc.6604484

DOI

http://dx.doi.org/10.1038/sj.bjc.6604484

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1048175725

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/18827808


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Intracellular Signaling Peptides and Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Membrane Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neovascularization, Pathologic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Signal Transduction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vascular Endothelial Growth Factor A", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, 10591, New York, NY, USA", 
          "id": "http://www.grid.ac/institutes/grid.418961.3", 
          "name": [
            "Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, 10591, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Thurston", 
        "givenName": "G", 
        "id": "sg:person.01154473176.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154473176.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Herbert Irving Comprehensive Cancer Center, Columbia University, 1130 St Nicholas Avenue, 10032, New York, NY, USA", 
          "id": "http://www.grid.ac/institutes/grid.21729.3f", 
          "name": [
            "Herbert Irving Comprehensive Cancer Center, Columbia University, 1130 St Nicholas Avenue, 10032, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kitajewski", 
        "givenName": "J", 
        "id": "sg:person.01102727732.79", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01102727732.79"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/nature05355", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037678066", 
          "https://doi.org/10.1038/nature05355"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc2130", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042233486", 
          "https://doi.org/10.1038/nrc2130"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature05571", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009360999", 
          "https://doi.org/10.1038/nature05571"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature05577", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045720229", 
          "https://doi.org/10.1038/nature05577"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/35102599", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009535704", 
          "https://doi.org/10.1038/35102599"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature05313", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034553835", 
          "https://doi.org/10.1038/nature05313"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2008-09-30", 
    "datePublishedReg": "2008-09-30", 
    "description": "Tumour angiogenesis has become an important target for antitumour therapy, with most current therapies aimed at blocking the VEGF pathway. However, not all tumours are responsive to VEGF blockers, and some tumours that are responsive initially may become resistant during the course of treatment, thus there is a need to explore other angiogenesis signalling pathways. Recently, the Delta-Notch pathway, and particularly the ligand Delta-like 4 (Dll4), was identified as a new target in tumour angiogenesis. An important feature in angiogenesis is the manifold ways in which the VEGF and Delta-Notch pathways interact. The emerging picture is that the VEGF pathway acts as a potent upstream activating stimulus for angiogenesis, whereas Delta-Notch helps to guide cell fate decisions that appropriately shape the activation. Here we review the two signalling pathways and what is currently known about the ways in which they interact during tumour angiogenesis.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/sj.bjc.6604484", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2536843", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "8", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "99"
      }
    ], 
    "keywords": [
      "tumor angiogenesis", 
      "VEGF pathway", 
      "course of treatment", 
      "most current therapies", 
      "ligand Delta-like 4", 
      "current therapies", 
      "Delta-like 4", 
      "VEGF blocker", 
      "antitumour therapy", 
      "angiogenesis", 
      "new targets", 
      "therapy", 
      "tumors", 
      "important target", 
      "VEGF", 
      "pathway", 
      "Delta-Notch pathway", 
      "blockers", 
      "target", 
      "treatment", 
      "activation", 
      "Delta-Notch", 
      "cell fate decisions", 
      "stimuli", 
      "fate decisions", 
      "course", 
      "need", 
      "features", 
      "important features", 
      "picture", 
      "decisions", 
      "upstream", 
      "way", 
      "manifold ways"
    ], 
    "name": "VEGF and Delta-Notch: interacting signalling pathways in tumour angiogenesis", 
    "pagination": "1204-1209", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1048175725"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.bjc.6604484"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "18827808"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.bjc.6604484", 
      "https://app.dimensions.ai/details/publication/pub.1048175725"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:52", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_461.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/sj.bjc.6604484"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604484'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604484'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604484'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604484'


 

This table displays all metadata directly associated to this object as RDF triples.

163 TRIPLES      21 PREDICATES      73 URIs      59 LITERALS      15 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.bjc.6604484 schema:about N232c49eefbd745399bfb5748ffcad7f9
2 N4a86e978afeb4cb28ca65ce18a54fd87
3 N5e85ea868dff4b96a8d3468b8e60fda9
4 N66766f1c2e7847818b8bb2bba8090b8b
5 N7180c3c109424aa8b53d196138104428
6 N7536a39a852d41bb8fe8a1151de67817
7 Ndf8ce679a0ec415396d1a03f44f01cf1
8 Ne66e73f26e59445cbae1346a2c515d63
9 anzsrc-for:11
10 anzsrc-for:1112
11 schema:author N4f9a48a9f5c34edda1f6418fdb892ff1
12 schema:citation sg:pub.10.1038/35102599
13 sg:pub.10.1038/nature05313
14 sg:pub.10.1038/nature05355
15 sg:pub.10.1038/nature05571
16 sg:pub.10.1038/nature05577
17 sg:pub.10.1038/nrc2130
18 schema:datePublished 2008-09-30
19 schema:datePublishedReg 2008-09-30
20 schema:description Tumour angiogenesis has become an important target for antitumour therapy, with most current therapies aimed at blocking the VEGF pathway. However, not all tumours are responsive to VEGF blockers, and some tumours that are responsive initially may become resistant during the course of treatment, thus there is a need to explore other angiogenesis signalling pathways. Recently, the Delta-Notch pathway, and particularly the ligand Delta-like 4 (Dll4), was identified as a new target in tumour angiogenesis. An important feature in angiogenesis is the manifold ways in which the VEGF and Delta-Notch pathways interact. The emerging picture is that the VEGF pathway acts as a potent upstream activating stimulus for angiogenesis, whereas Delta-Notch helps to guide cell fate decisions that appropriately shape the activation. Here we review the two signalling pathways and what is currently known about the ways in which they interact during tumour angiogenesis.
21 schema:genre article
22 schema:isAccessibleForFree true
23 schema:isPartOf N0817fc3cc9f145099c5877b7a1f954e1
24 Nbb5a3df593b84a60b11d23b241451f1a
25 sg:journal.1017082
26 schema:keywords Delta-Notch
27 Delta-Notch pathway
28 Delta-like 4
29 VEGF
30 VEGF blocker
31 VEGF pathway
32 activation
33 angiogenesis
34 antitumour therapy
35 blockers
36 cell fate decisions
37 course
38 course of treatment
39 current therapies
40 decisions
41 fate decisions
42 features
43 important features
44 important target
45 ligand Delta-like 4
46 manifold ways
47 most current therapies
48 need
49 new targets
50 pathway
51 picture
52 stimuli
53 target
54 therapy
55 treatment
56 tumor angiogenesis
57 tumors
58 upstream
59 way
60 schema:name VEGF and Delta-Notch: interacting signalling pathways in tumour angiogenesis
61 schema:pagination 1204-1209
62 schema:productId N4fb9f47c330c42d8a5a996d9469cdcd3
63 N681813123fbc4bbe86f7d19d570f3bef
64 N7dce8b251f9242bfa1f627435a7abaad
65 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048175725
66 https://doi.org/10.1038/sj.bjc.6604484
67 schema:sdDatePublished 2022-09-02T15:52
68 schema:sdLicense https://scigraph.springernature.com/explorer/license/
69 schema:sdPublisher N1e98f4019703431083fba286280371c4
70 schema:url https://doi.org/10.1038/sj.bjc.6604484
71 sgo:license sg:explorer/license/
72 sgo:sdDataset articles
73 rdf:type schema:ScholarlyArticle
74 N0817fc3cc9f145099c5877b7a1f954e1 schema:issueNumber 8
75 rdf:type schema:PublicationIssue
76 N1e98f4019703431083fba286280371c4 schema:name Springer Nature - SN SciGraph project
77 rdf:type schema:Organization
78 N1fb30159080b4c9388483b64d73a6a08 rdf:first sg:person.01102727732.79
79 rdf:rest rdf:nil
80 N232c49eefbd745399bfb5748ffcad7f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Intracellular Signaling Peptides and Proteins
82 rdf:type schema:DefinedTerm
83 N4a86e978afeb4cb28ca65ce18a54fd87 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Humans
85 rdf:type schema:DefinedTerm
86 N4f9a48a9f5c34edda1f6418fdb892ff1 rdf:first sg:person.01154473176.34
87 rdf:rest N1fb30159080b4c9388483b64d73a6a08
88 N4fb9f47c330c42d8a5a996d9469cdcd3 schema:name doi
89 schema:value 10.1038/sj.bjc.6604484
90 rdf:type schema:PropertyValue
91 N5e85ea868dff4b96a8d3468b8e60fda9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Neovascularization, Pathologic
93 rdf:type schema:DefinedTerm
94 N66766f1c2e7847818b8bb2bba8090b8b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Vascular Endothelial Growth Factor A
96 rdf:type schema:DefinedTerm
97 N681813123fbc4bbe86f7d19d570f3bef schema:name dimensions_id
98 schema:value pub.1048175725
99 rdf:type schema:PropertyValue
100 N7180c3c109424aa8b53d196138104428 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Neoplasms
102 rdf:type schema:DefinedTerm
103 N7536a39a852d41bb8fe8a1151de67817 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Signal Transduction
105 rdf:type schema:DefinedTerm
106 N7dce8b251f9242bfa1f627435a7abaad schema:name pubmed_id
107 schema:value 18827808
108 rdf:type schema:PropertyValue
109 Nbb5a3df593b84a60b11d23b241451f1a schema:volumeNumber 99
110 rdf:type schema:PublicationVolume
111 Ndf8ce679a0ec415396d1a03f44f01cf1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Membrane Proteins
113 rdf:type schema:DefinedTerm
114 Ne66e73f26e59445cbae1346a2c515d63 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Animals
116 rdf:type schema:DefinedTerm
117 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
118 schema:name Medical and Health Sciences
119 rdf:type schema:DefinedTerm
120 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
121 schema:name Oncology and Carcinogenesis
122 rdf:type schema:DefinedTerm
123 sg:grant.2536843 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.bjc.6604484
124 rdf:type schema:MonetaryGrant
125 sg:journal.1017082 schema:issn 0007-0920
126 1532-1827
127 schema:name British Journal of Cancer
128 schema:publisher Springer Nature
129 rdf:type schema:Periodical
130 sg:person.01102727732.79 schema:affiliation grid-institutes:grid.21729.3f
131 schema:familyName Kitajewski
132 schema:givenName J
133 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01102727732.79
134 rdf:type schema:Person
135 sg:person.01154473176.34 schema:affiliation grid-institutes:grid.418961.3
136 schema:familyName Thurston
137 schema:givenName G
138 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154473176.34
139 rdf:type schema:Person
140 sg:pub.10.1038/35102599 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009535704
141 https://doi.org/10.1038/35102599
142 rdf:type schema:CreativeWork
143 sg:pub.10.1038/nature05313 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034553835
144 https://doi.org/10.1038/nature05313
145 rdf:type schema:CreativeWork
146 sg:pub.10.1038/nature05355 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037678066
147 https://doi.org/10.1038/nature05355
148 rdf:type schema:CreativeWork
149 sg:pub.10.1038/nature05571 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009360999
150 https://doi.org/10.1038/nature05571
151 rdf:type schema:CreativeWork
152 sg:pub.10.1038/nature05577 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045720229
153 https://doi.org/10.1038/nature05577
154 rdf:type schema:CreativeWork
155 sg:pub.10.1038/nrc2130 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042233486
156 https://doi.org/10.1038/nrc2130
157 rdf:type schema:CreativeWork
158 grid-institutes:grid.21729.3f schema:alternateName Herbert Irving Comprehensive Cancer Center, Columbia University, 1130 St Nicholas Avenue, 10032, New York, NY, USA
159 schema:name Herbert Irving Comprehensive Cancer Center, Columbia University, 1130 St Nicholas Avenue, 10032, New York, NY, USA
160 rdf:type schema:Organization
161 grid-institutes:grid.418961.3 schema:alternateName Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, 10591, New York, NY, USA
162 schema:name Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, 10591, New York, NY, USA
163 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...